AC Immune
Eva Sabrina Gollwitzer is a seasoned scientist currently serving as a Senior Scientist at AC Immune since September 2017, having previously held the position of Research Scientist. Prior to this role, Eva worked as a Postdoctoral Research Fellow at Ecole polytechnique fédérale de Lausanne from May 2015 to September 2017. Educationally, Eva holds a Doctor of Philosophy (PhD) in Immunology from the University of Lausanne, completed in 2015, as well as a Master of Science (M.Sc.) in Cell/Cellular and Molecular Biology and a Bachelor of Science (B.Sc.) in General Biology, both obtained from FAU Erlangen-Nürnberg.
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.